- Apr 28, 2021 Foghorn Therapeutics Appoints Ian Smith to its Board of Directors
- Mar 18, 2021 Foghorn Therapeutics Provides Corporate Update
- Mar 11, 2021 UPDATE: Foghorn Therapeutics to Present Poster and Chair a Panel at the AACR Annual Meeting 2021
- Feb 22, 2021 Foghorn Therapeutics to Participate in the 41st Cowen Annual Healthcare Conference
- Dec 04, 2020 Foghorn Therapeutics Announces Third Quarter 2020 Financial Results and Provides Corporate Update
- Nov 12, 2020 Foghorn Therapeutics Appoints Michael LaCascia as Chief Legal Officer
- Oct 22, 2020 Foghorn Therapeutics Announces Pricing of Initial Public Offering
- Jul 08, 2020 Foghorn® Therapeutics Announces Collaboration with Merck to Discover and Develop Novel Oncology Therapeutics Against Transcription Factor Target
- Jan 09, 2020 Foghorn® Therapeutics Appoints Scott Biller, Ph.D., to Board of Directors
- Sep 16, 2019 Foghorn® Therapeutics Expands Leadership Team with Two C-Suite Appointments
Displaying 81 - 90 of 92